CRISPR-Cas-enabled nanocarriers in hepatocellular carcinoma: Emerging gene-editing strategies for precision liver therapy

Hepatocellular carcinoma (HCC) remains a highly deadly global malignancy with limited curative treatments, frequent recurrence, and delayed diagnosis. Gene editing systems using CRISPR-Cas offer great potential to correct cancer-causing mutations, reprogram the tumor microenvironment, and overcome d...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Ramaiyan Velmurugan, Yokesh Shanmugam, Lokeshvar Ravikumar
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	KeAi Communications Co., Ltd. 2026-04-01
Edice:	Gastroenterology & Endoscopy
Témata:	CRISPR-Cas9 hepatocellular carcinoma Gene therapy Nanocarriers Lipid nanoparticles Targeted delivery
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2949752326000105
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!